Kennedy Removes COVID-19 Vaccine Recommendations
Analysis based on 8 articles · First reported May 27, 2025 · Last updated May 28, 2025
The policy change by Robert F. Kennedy Jr. is likely to negatively impact pharmaceutical companies that produce COVID-19 vaccine, as the market for these vaccines will shrink due to reduced recommendations. It also creates uncertainty and potential volatility in the healthcare sector as public health guidance shifts, affecting investor confidence in related industries.
U.S. Health Secretary Robert F. Kennedy Jr. announced on May 27 that COVID-19 vaccines are no longer recommended for healthy children and pregnant women. This decision, made without the direct involvement of United States — Centers for Disease Control and Prevention officials in the announcement video, contradicts previous guidance from U.S. health officials who advocated for annual boosters for all Americans aged six months and older. Robert F. Kennedy Jr., a known anti-vaccine advocate, stated that annual booster shots for children were recommended despite a lack of clinical data. The United States — Food and Drug Administration had also recently announced limitations on routine COVID-19 vaccine approvals to seniors and individuals with underlying medical risks. The United States — United States Department of Health and Human Services officials have not provided further details on the decision.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard